$30.03
-0.58-1.89%
Last update: Nov 10, 7:33 PM
Vera Therapeutics Inc
VERANASDAQ
Vera Therapeutics rose 10.3% from $27.75 to $30.61, ahead of the S&P 500's +10.0%. Its worst day was Sep 23 (−8.9%), and its low came Oct 14 at $26.74.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Vera Therapeutics shares rose 22.3%, while the S&P 500 rose 0.1%.
+22.3%, the year's best day · S&P 500 +0.1%
Vera Therapeutics closed at its highest level of the year, 100.6% above where the year started.
Story events cover the past 12 months · Times ET
+3.3% · S&P 500 +0.4%
EPS of $-1.39 missed the $-1.30 estimate on $0.00 revenue.
+1.6% · S&P 500 −0.6%
Vera Therapeutics shares rose 10.0%, while the S&P 500 fell 0.1%.
+10.0% · S&P 500 −0.1%
EPS of $-1.69 missed the $-1.35 estimate on $0.00 revenue.
−2.0% · S&P 500 −0.3%
EPS of $-1.52 beat the $-1.59 estimate on $0.00 revenue.
−4.1% · S&P 500 −0.3%
Vera Therapeutics closed at its lowest level of the year, 3.6% below where the year started.
−0.2% · S&P 500 −1.1%
EPS of $-1.30 beat the $-1.64 estimate on $10.3M revenue (est. $3.2M).
−1.2% · S&P 500 +0.3%
Where it ended: a close of $30.61 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-1.44, revenue est. $21.7M).
Nothing in the past 12 months.
All VERA dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VERA and SPY from Benzinga historical bars. Not investment advice.
